BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2544215)

  • 1. Interaction of HIV and EBV at lymphoid tissue level: immunohistochemistry and in situ hybridization.
    Uccini S; Vitolo D; Monardo F; Faggioni A; Monarca B; Vitale A; Ruco LP; Baroni CD
    APMIS Suppl; 1989; 8():28-32. PubMed ID: 2544215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) antigens and genome in lymph nodes of HIV-positive patients affected by persistent generalized lymphadenopathy (PGL).
    Uccini S; Monardo F; Vitolo D; Faggioni A; Gradilone A; Aglianó AM; Manzari V; Ruco LP; Baroni CD
    Am J Clin Pathol; 1989 Dec; 92(6):729-35. PubMed ID: 2556016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [EBV-lymphadenitis: diagnostic possibilities using immunohistochemistry and in situ hybridization].
    Peters J; Tiemann M; Dietel M; Parwaresch MR
    Verh Dtsch Ges Pathol; 1992; 76():211-2. PubMed ID: 1283261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of HIV in lymph node cells of LAS patients. Immunohistology, in situ hybridization, and identification of target cells.
    Baroni CD; Pezzella F; Pezzella M; Macchi B; Vitolo D; Uccini S; Ruco LP
    Am J Pathol; 1988 Dec; 133(3):498-506. PubMed ID: 3202117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the topography of Epstein-Barr virus infection in human immunodeficiency virus-associated lymphoid tissues.
    Arber DA; Shibata D; Chen YY; Weiss LM
    Mod Pathol; 1992 Sep; 5(5):559-66. PubMed ID: 1344820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
    Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
    Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
    Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
    J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
    J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of p24 HTLV3 major core protein in lymph nodes of LAS patients.
    Baroni CD; Pezzella F
    Cancer Detect Prev Suppl; 1987; 1():553-6. PubMed ID: 3121180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of Epstein-Barr virus DNA in tonsillar tissues.
    Brichácek B; Suchánková A; Hirsch I; Síbl O; Rezácova D; Závadová H; Vonka V
    Acta Virol; 1981 Nov; 25(6):361-70. PubMed ID: 6120637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph nodes in HIV-positive drug abusers with persistent generalized lymphadenopathy: histology, immunohistochemistry, and pathogenetic correlations.
    Baroni CD; Uccini S
    Prog AIDS Pathol; 1990; 2():33-50. PubMed ID: 2103864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sampling lymph node content of human immunodeficiency virus type 1 nucleic acids and p24 antigen by fine-needle aspiration in early-stage patients.
    Anderson DW; DeNobile J; Zhao F; Vahey M; Lane J; Nau M; Brown AE; Wegner SA; Malone JD; Wagner K
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S57-61. PubMed ID: 7552514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of EBV-infected cells in HIV-related lymphadenopathy: implications for the pathogenesis of EBV-associated and EBV-unrelated lymphomas of HIV-seropositive individuals.
    Dolcetti R; Gloghini A; De Vita S; Vaccher E; De Re V; Tirelli U; Carbone A; Boiocchi M
    Int J Cancer; 1995 Nov; 63(5):652-9. PubMed ID: 7591281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus distribution in nonneoplastic lymph nodes.
    Deamant FD; Albújar PF; Chen YY; Weiss LM
    Mod Pathol; 1993 Nov; 6(6):729-32. PubMed ID: 8302816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Epstein-Barr virus-infected mucosal lymphocytes in nasal polyps.
    Tao Q; Srivastava G; Dickens P; Ho FC
    Am J Pathol; 1996 Oct; 149(4):1111-8. PubMed ID: 8863660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Simultaneous detection of IgM antibodies against the hepatitis A virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis].
    Naveau S; Delfraissy JF; Poitrine A; Poynard T; Chaput JC
    Gastroenterol Clin Biol; 1985 Feb; 9(2):109-12. PubMed ID: 2984075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen.
    Dong L; Masaki Y; Takegami T; Kawanami T; Itoh K; Jin ZX; Huang CR; Tong XP; Fukushima T; Tanaka M; Sawaki T; Sakai T; Sugai S; Okazaki T; Hirose Y; Umehara H
    Int Immunol; 2007 Mar; 19(3):331-6. PubMed ID: 17272286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.